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Abstract
Purpose—The purpose of this study was to assess adolescent women’s preferences for specific
microbicide characteristics including: pregnancy prevention, timing of application, potential for side
effects, and whether it targeted Human Immunodeficiency Virus (HIV) or other sexually transmitted
infections (STI). Potential differences in microbicide preferences by adolescent age group and
behavioral patterns, including engaging in sexual intercourse and use of hormonal contraception,
were examined, as it was hypothesized that as adolescents progress into adulthood and gain sexual
experience their preferences in microbicide characteristics may shift.
Method—Adolescent and young women (N = 405, 56.0% African American; 24.0% Euro-
American) between the ages of 14 and 20 (M = 17.0, SD = 1.8) were recruited from urban community-
based clinics. Video-Audio Computer-Assisted Self-Interviews (VACASI) were conducted with the
young women during which they were asked about their preferences regarding the characteristics of
hypothetical vaginal microbicides. Conjoint analysis was utilized to determine adolescent women’s
relative preferences for each microbicide characteristic and intent-to-purchase microbicides based
upon a combination of the selected properties.
Results—Overall, the results suggest adolescent and young women had an ordered preference for
a microbicide with (1) no side effects, (2) pregnancy prevention, (3) post-coital application, and (4)
protection against HIV. Age and behavioral group conjoint analyses resulted in the same pattern of
preferences as those reported for the entire group. However, women having sex and not using
hormonal contraception had a stronger preference for post-coital application.
Conclusion—The findings suggest that young women’s ratings of microbicides were sensitive to
characteristics such as side effects, pregnancy prevention, and timing of application. The conjoint
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analysis approach is useful in understanding microbicide preferences and should be utilized with
other populations to assess preferences for specific microbicide characteristics.
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Introduction
The search for a woman-initiated prevention method has led to focus on topical microbicides
for STI/HIV prevention. Microbicides are substances that may substantially reduce
transmission of STI when applied in the vagina or rectum [1]. Some microbicides may also
prevent pregnancy, although not all microbicides will be contraceptive [2]. Microbicides are
currently not commercially available; products are in various phases of clinical trials [1]. Most
microbicides under development are coitus-dependent, requiring women to recognize and
prepare for sexual situations and be willing to use a product that requires some comfort with
touching their genitals [3]. The process of inserting a microbicide into the vagina may be
challenging as the dialogue around young women’s sexuality and their bodies is often lacking
[4]. Acceptability research, therefore, remains crucial in order to anticipate and prospectively
address the kinds of obstacles previously associated with other female-initiated products, such
as the female condom [5,6]. For instance, while women enjoyed having more control in using
the female condom, they often did not like the size and discomfort associated with use or the
inability to use it covertly [6].
Extant microbicide acceptability research with young women has indicated that contraceptive
and disease prevention properties, timing of use, and associated side effects are important
characteristics [7]. The findings suggest that young women generally prefer both pregnancy
and disease prevention in a single product and insertion with an applicator up to eight hours in
advance [8]. In addition, there is a preference for lubricating products [9,10] with low amounts
of messiness [9] and leakage [8]. Previous research also indicates that relevant potential side
effects may impact microbicide use, including yeast infections, vaginal itching, and allergic
reactions [7,11]. Furthermore, access was an important gauge of acceptability in a group of
adolescent women. Women indicated that microbicides should be promoted through
“adolescent-specific and girl-specific venues,” including women’s magazines [7]. There was
also a reported desire for microbicides that would be small enough to carry in their pocket, bra,
or within cell phone or palm pilot cases, and should be distributed through schools and sexuality
education classes [7]. Most young women preferred over-the-counter availability of
microbicides, yet stated they would be embarrassed if purchasing the product in the presence
of others [7,8].
Thus far, microbicide acceptability research with adolescents has been conducted primarily
with older adolescents, using individual interview and focus group methodologies [7,9,11–
16]. These qualitative methodologies allow for an in-depth assessment of individual as well as
relational and age-related issues that may influence microbicide use [13,17]. However, social
desirability is often a concern when studying stigmatized or socially sensitive issues associated
with sexuality [18,19]. Past research has shown that using a Video-Audio Computer-Assisted
Self-Interview (VACASI) format (participants privately responding to questions on a
computer) for presenting survey questions alleviates the tendency for individuals to present
themselves positively and answer questions in a socially desirable fashion [20]. In addition,
women and adolescents report sensitive behaviors more frequently when questions are asked
using computer interviewing techniques than when participating in a face-to-face interview
[20–22]. Existing microbicide acceptability research with adolescents also often lacks detailed
attention to the multiple dimensions that must be considered simultaneously in a decision to
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try a product such as a microbicide. The addition of quantitative biopsychosocial studies
addressing these issues thus complements the existing qualitative microbicide acceptability
research [8,23–24].
The purpose of this study was to quantitatively assess, using full profile ratings based conjoint
analysis, preferences for specific microbicide characteristics among a young, urban population
of women. Building on existing literature we chose to assess young women’s preferences for
pregnancy and STI (including HIV) prevention as well as timing of application and side effect
potential. It was hypothesized that as women progress through the adolescent years, their
relative preferences for specific microbicide characteristics may change as a function of their
age and sexual experience.
Methods
Study participants
Participants were 405 adolescent and young women between the ages of 14 and 20 (M = 17,
SD = 1.8) recruited from community-based urban health clinics in the Midwestern United
States in an area with relatively low rates of HIV [25]. Informed consent was received from
all participants. For women 18 years old and over consent was received directly and for those
younger than 18 years of age parental permission as well as adolescent consent were received.
Before obtaining consent, the research assistant explained to the young woman (and her parent)
the details, procedure, and duration of the study. See Table 1 for participant demographics.
Development of Study Methodology
VACASI was used in the study to increase the validity of the information received from the
adolescent women. The VACASI content for this study was developed from a pilot study
designed to elicit a range of issues relevant to the examination of adolescents’ acceptability of,
and preference, for microbicides. Focus groups, individual interviews, and dyad interviews
were conducted, transcribed verbatim, and the results analyzed to determine the characteristics
of microbicides most often mentioned and about which adolescents expressed the greatest
concern. Individual interviews and a card sort methodology were used to additionally develop
ranked preferences for microbicide target (HIV versus other STI), timing of application (before
or after sex), contraceptive properties, and types of side effects [26]. Based on these pilot data,
a VACASI script was developed, further pilot tested, and finalized for use in the current study.
Study procedure
After informed consent was received, the young women were given a computer and headphones
in a private exam room to begin the questionnaire. The VACASI began with participants being
asked to choose one of four possible “guides” whose face and voice were used throughout the
VACASI. Guides were young women (approximately 18 – 20 years old) who were professional
actors of varied ethnic appearance and voice. The guides were used to increase young women’s
level of comfort with the interview [27]. Following the choice of a guide, more information
was given about the microbicide and a product sample was shown. The participant was then
asked multiple demographic and sexual behaviors questions and presented with microbicide
vignettes that asked her to rate the likelihood of buying each microbicide. The self-interviews
were completed in English and lasted 25 – 45 minutes. Participants received $20 compensation
for the time and effort involved in completing the questionnaire. The protocols for the entire
project were approved by the University’s Institutional Review Board.
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Study measures
Background—Demographic information was collected from each participant including: age,
race, ethnicity, and education. Participants also answered questions regarding their sexual
behaviors (e.g., Has a partner ever put his penis in your vagina?) and contraceptive use (e.g.,
What kinds of birth control have you used in the past month?).
Microbicide preferences—Eight microbicide formulas were uniquely described along four
specific dimensions, with multiple attributes within each dimension, to assess participants’
relative preference for each individual property. Table 2 summarizes the microbicide formulas.
The first dimension, contraception, contained two attributes—whether the microbicide would
prevent pregnancy or not. The second dimension, timing, was related to the timing of
microbicide application in relation to coitus (attributes—1 hour pre-coital, 15 minutes pre-
coital, or 10 minutes post-coital application). The third dimension, target, was defined in terms
of what infections were prevented by the microbicide (attributes—HIV only or other STI but
not HIV). The final dimension, side effects, varied with respect to side effects (attributes—
burning and itching in 10% of women or no side effects at all). The product profiles were
presented in random sequence across participants and women were asked to rate their intent
to purchase each microbicide formula.
Intent to purchase microbicides—Intent to purchase microbicides was measured by
asking participants to rate each of eight microbicides using a 7-point likelihood scale, ranging
from “extremely unlikely to buy” to “extremely likely to buy.” As we were uncertain what the
cost of microbicides would be, we asked respondents to assume that the cost of microbicides
would be approximately the same as condoms. Recent estimates, however, suggest that
microbicides will cost approximately $1 per application [28].
Data Analysis
Data management and analysis were performed using SPSS 15.0 [29]. Descriptive statistics
were conducted to assess the demographic variables. The quantitative marketing research
technique, conjoint analysis, was employed in order to assess preference for specific
microbicide characteristics and formulas among young women. Conjoint analytic techniques
are commonly used to evaluate how product characteristics influence the product acceptability,
often while the product is still in development [30]. Conjoint analysis allows for the assessment
of the relative preference women have for microbicide characteristics (e.g., contraceptive
properties, timing of application).
The full profile ratings based conjoint analysis technique used in this study incorporates a
fractional factorial design and is a regression based analytic approach to examine how different
product dimensions influence intent to purchase [31]. Conjoint analysis allows for multiple
product characteristics to be simultaneously assessed with a relatively small number of items
that minimizes the burden to the respondent (i.e., a fractional factorial design) [8,32]. The
conjoint analysis technique has been applied in several health care preference studies [33–
37] and one other microbicide acceptability study, with considerable differences in terms of
sample demographics and product characteristics [8].
Using the aforementioned dimensions (contraception, timing, target, and side effects), 24
microbicide formulas would have to be rated to assess every combination of attributes.
However, a fractional factorial design allows for the examination of representative sub-sample
of eight microbicide formulas, thus reducing respondent burden (see Table 2 for microbicide
formulations). By having the respondents evaluate each of the eight product constructions, we
were able to estimate the effect of each product characteristic on purchase intentions. A
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limitation of the fractional factorial design is that only the main effects of each dimension can
be assessed, as only a relatively small subset of all possible combinations are presented.
Full profile rating based conjoint analysis results in part-worth utilities and importance scores
[8,32]. Part-worth utilities reflect the relative value placed on the specific attributes within each
dimension, for example contraceptive compared to non-contraceptive. A negatively rated part-
worth utility indicates a relative antipathy for a particular attribute whereas a positively rated
part-worth utility indicates a relative preference for an attribute. This approach to conjoint
analysis also provides importance scores, which summed across all dimensions equal 100. The
higher the importance score for a given dimension, the greater the influence on microbicide
ratings. Part-worth utilities summed within a given dimension equal zero with a greater range
in utilities translating into a higher importance score for a given dimension.
Results
Descriptive statistics: Overall sample
The women (N = 405) were between the ages of 14 and 20 years, with a mean age of 17 (SD
= 1.8). Of these women, 56.0% (n = 227) were African American, 24.0% (n = 97) were Euro-
American, 5.4% (n = 22) were Latina, and the remainder identified as other or mixed ethnic
and racial backgrounds. On average, women had completed 10.3 years of education (SD =
1.6), with 23.5% (n = 94) having completed high school and 6.8% (n = 27) having completed
some college. Of the women, 67.7% (n = 275) had engaged in sexual intercourse, and 52.8%
(n = 214) were currently using a hormonal contraceptive. Participant characteristics for the
entire sample and the groups divided by age category are summarized in Table 1.
Descriptive statistics: Age & behavioral group
As we were interested in developmental changes, women were divided by age and sexual and
contraceptive experiences into groups. This allowed between group comparisons with respect
to the microbicide preference profiles provided by the conjoint analyses. The three age
categories were defined as: 14 and 15 year olds (n = 100, 24.9%), 16 and 17 year olds (n =
124, 30.6%), and women age 18 to 20 (n = 181, 44.7%). Conceptually, these age groups (i.e.,
14 & 15 year olds; 16 & 17 year olds; and those 18 and older) represent middle adolescence,
late adolescence, and emerging adulthood. The women 18 years of age and older, as legal
adults, differ in sexual rights from the rest of the sample. Differences existed among age groups
in terms of sexual behaviors and contraceptive experience. Among 14–15 year olds, less than
half had engaged in sexual intercourse (43.9%, n = 43) or using hormonal contraception
(34.1%, n = 31). The majority of the age 18 and older women had engaged in sexual intercourse
(86.3%, n = 151) and were using hormonal contraception (71.2%, n = 126). In contrast, less
than half of 16–17 year olds were using hormonal contraception (47.9%, n = 57) although most
reported ever having sexual intercourse (65.9%, n = 81). Therefore, the behavioral groups
consisted of women who had never had intercourse (n = 121, 29.9%), were engaging in
intercourse and not using hormonal contraception (n = 89, 22.0%), and were engaging in
intercourse and using hormonal contraception (n = 181, 44.7%). Group characteristics are
summarized in Table 1.
Microbicide intent-to-purchase
On the 7-point response scale (ranging from 1 = extremely unlikely to by to 7 = extremely
likely to buy), the mean intent-to-purchase ratings ranged from 3.38 (SD = 2.04) to 5.35 (SD
= 1.76) across the eight different microbicide formulas. The microbicide with the highest
intention rating had these properties: contraceptive, application 10 minutes post-coitus,
protecting against HIV only, and not having side effects. The microbicide with the lowest
Tanner et al. Page 5
J Adolesc Health. Author manuscript; available in PMC 2009 October 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
intention to purchase had the following characteristics: non-contraceptive, application 1hour
pre-coitus, protecting against HIV only, and having side effects.
Microbicide preference: Entire sample
Relative attribute preferences as determined by conjoint analysis could only be calculated from
subject data in which there was variability across the eight microbicides. Twenty-two women
(5.4% of the total sample) rated all microbicides at the same level and were therefore not
included in the conjoint analysis results. The part-worth utility (PWU) results (Figure 1) for
the remaining 94.6% of the sample indicated strong relative preferences for contraceptive
properties (PWU, 0.37) and for no side effects (PWU, 0.55). In addition, there was a moderate
preference for 10-minute post-coital application (PWU, 0.14), and a slight preference for a
microbicide that targets other STI, but not HIV (PWU, 0.04). In contrast, the following
microbicide attributes were viewed as relatively less preferable: no contraceptive action (PWU,
−0.37), side effects (PWU, −0.55), applied one hour before coitus (PWU, −0.14), and targeted
HIV only (PWU, −0.04).
Reflecting the PWU results, the majority of women indicated a relative preference for
contraception (n = 249; PWU = .13 to 2.38). However, a reasonably large minority of
respondents expressed a relative preference for non-contraception (n = 74; PWU = 0.13 to
2.25), with the remaining women not distinguishing between contraception and non-
contraception. Also, although most women expressed a relatively negative response to side-
effects (n = 292; PWU = −0.13 to −.2.50), for 43 women, side effects were viewed as relatively
unimportant as reflected in low, positive PWU (ranging from 0.13 to 0.88). With respect to
timing, 161 indicated a preference for post-coital application (PWU = 0.08 to 3.50), 92
preferred 15 minutes pre-coitus (PWU = 0.25 – 2.83), and 89 expressed a preference for one
hour pre-coitus (PWU = 0.17 – 2.67). Respondents were relatively equally divided in
preference for either HIV prevention (n = 152; PWU = 0.13 to 2.50) or prevention of other
STDs (n = 168; PWU = 0.13 to 2.25).
Side effects most strongly influenced ratings with an importance score of 50.1 followed by
contraceptive properties with an importance score of 33.6 and timing with an importance score
of 13.0. The microbicide target did not substantially influence ratings (importance score, 3.4).
Importance scores, in total, add up to 100, therefore, side effects and contraceptive effect were
the strongest influences on young women’s microbicide preferences.
Microbicide preference: Age and behavioral groups
We calculated conjoint analysis results separately on the basis of both age group and sexual
and contraceptive behavior experiences. Results indicated that all of the age and behavioral
groups had the same pattern of preferences for the combination of microbicide characteristics
as the overall group (i.e., not having side effects followed by having contraceptive properties).
In order to evaluate differences that may exist within the behavioral groups we conducted a
series of analysis of variance (ANOVA) tests with sexual and contraceptive behavior group as
the independent variable and the PWU associated with different microbicide attributes (i.e.,
no side effects) as the dependent variables. After the application of the Dunnet’s post hoc test,
results indicated one significant ANOVA [F(2,342) = 3.6, p < .05] suggesting that women
having sex and using condoms had a stronger preference for post-coital application compared
to those women currently having sex and using hormonal contraception.
Discussion
This study examined adolescent and young women’s preference for specific microbicide
characteristics utilizing full profile ratings based conjoint analysis. Similar to existing research
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[7,11], young women’s preferences were sensitive to side effects, contraceptive properties, and
timing of application. Specifically, adolescent women reported an ordered preference for a
microbicide with no side effects, having contraceptive properties, applied 10 minutes post-
coitally, and protecting against STI rather than HIV.
Young women’s preferences were most influenced by side effects and contraceptive properties.
Lack of side effects was the most preferential microbicide characteristic for the overall sample.
It is interesting that young women would be primarily concerned with side effects given that
the option was that there would either be no side effects or side effects in 10% of women. This
may reflect young women’s experiences with negative side effects of existing hormonal
contraceptive methods [10] or be a result of young women’s assumption that they would be
the ones to have side effects. The concern related to side effects for these women suggests it
will be essential for health care providers to discuss the likelihood of side effects with young
women so they are not surprised and will continue to use microbicides for protection.
Contraceptive properties were the second most favored characteristic for the young women,
including for women who were currently using hormonal contraception. These results may
reflect the saliency of pregnancy in this population of young women and will be an important
characteristic to discuss with women as early generation microbicides may not be contraceptive
[2].
In contrast to other research that suggests adolescent women have a preference for microbicide
application up to 8 hours in advance [8], young women in the current study preferred a
microbicide that was applied 10 minutes post-coitus, or 15 minutes pre-coitus, compared to
one applied 1 hour before intercourse. Women’s relative preference for the 10 minutes post-
coital application could be explained by their desire to separate microbicide use from
intercourse. This result may also be reflective of the appeal of the possibility of using
microbicides surreptitiously due to the difficulties often associated with sexual communication
for young women and the ability to avoid direct discussions related to microbicide application
that is after coitus [9,15]. Similarly, the antipathy toward the 1 hour pre-coital application is
likely explained by the often unplanned nature of sexual interactions among adolescents [10].
In addition, while the lubricating effects of a pre-coital microbicide may be attractive to some
young women, post-coital application was viewed in a more positive light, this result may be
due to lack of knowledge related to the potential of lubrication to enhance sexual comfort. The
lubricating potential of microbicides may be an attractive characteristic, especially for
combining use with condoms to increase comfort for individuals who choose to use condoms.
As a group, adolescent and young women were slightly more accepting of a vaginal microbicide
that prevented STI other than HIV as compared to a vaginal microbicide that protected against
HIV only. This preference is interesting, as HIV has far fewer treatments than those available
to treat and cure other STI [38]. However, the relative disinterest in HIV prevention may reflect
the very low prevalence of HIV and the saliency of other STI for the study population [35,
39]. HIV prevalence will likely have implications for microbicide marketing based on
geography, where highlighting potential for HIV protection may be more useful in higher
prevalence areas while highlighting other characteristics may be more beneficial in other areas.
Our findings suggest that young women’s ratings of microbicides were responsive to
characteristics such as side effects, pregnancy prevention, and timing of application. They were
most likely to indicate an intent to purchase a microbicide that was contraceptive, applied 10
minutes post-coitally, protected against STI, and did not have side effects. However, it is
important to note that a substantial number of the women preferred characteristics other than
those identified as preferred by the group as a whole. These findings suggest that in the future
a variety of microbicide formulations will be useful as not all women (and their partners) will
have preferences for the same characteristics. In addition, while we did not find a significant
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difference in preferences by age group or behavioral factors age, sexual experiences, and use
of hormonal contraceptives may play an important and complex role in microbicide preferences
and utilization based on specific microbicide characteristics. Thus, more mixed methodological
work will be helpful in examining the individual variation in sexual and contraceptive
experience. Shifts in attitudes across varying levels of sexual experiences may reflect
developmental changes in reproductive health behaviors and priorities and may be important
considerations for the promotion and social marketing of microbicides. The availability of
microbicides with differing characteristics will allow microbicide formulas to be targeted to
the specific needs of women and may increase the likelihood of use. That said, we recognize
the ongoing difficulties associated with creating one effective microbicide and realize that this
variety will not be available for some time.
Full profile ratings based conjoint analysis, a marketing research tool, was used in the study
to examine adolescent women’s relative preference for microbicide characteristics. This
approach to data analysis is a unique way of examining the complicated microbicide
preferences of adolescent women and how these preferences might differ based upon individual
factors. While conjoint analysis has been used effectively in marketing research and suggests
a level of interest it does not indicate the likelihood of continued use [8,36–37,32]. However,
intention has been shown to be predictive of actual behavior [40] and without an actual product
available the starting point needs to be intent as intent is a key antecedent to behavior. In
addition, the dimensions chosen for the study may not be reflective of an actual product, as we
have limited knowledge regarding the characteristics of early generation microbicides [1,28].
Using the VACASI technique to collect data in the present study allowed for more privacy in
data collection, helping prevent much of the response bias and socially desirable answering
often associated with collecting sexuality-related data. Therefore, it is probable that the intent
to purchase results reported here are more valid than results collected during a face-to-face
interview.
Due to the nature of the clinics in which these women were recruited, incidence of sexual
intercourse as well as experiences with STI might be greater than in the general population and
their preferences may not be reflective of the larger population. In addition, as women were
asked about hypothetical microbicide products, we were not able to evaluate what their
experience would be with actual microbicide use. The inability to assess young women’s use
of a product disregards their bodily experience (either positive or negative) or how a
microbicide would be introduced into and negotiated within a sexual relationship should be
examined in future research. In addition, we were not able to capture relationship specific
information (e.g., quality, length) that may impact women’s desire and ability to use a future
microbicide [10].
This study expands on existing adolescent microbicide acceptability research and future
research in this area may benefit from utilizing conjoint analysis. Additionally, the combination
of conjoint analysis techniques with qualitative methodologies could be useful in assessing
microbicide preferences and reasoning at an individual level. This combined approach would
allow for a more in-depth examination of some of the issues related to young women’s sexual
experiences, the relationship with their bodies, and their sexual interest and pleasure. For
instance, recent work has suggested that the lubricating properties of microbicides may be a
highlight of use and may be of higher value to some women compared to others [9,10]. The
implications of introducing a product with lubricating qualities into a sexual interaction and
the potential impact on relationship and sexual satisfaction should be assessed as they may be
important determinants of continued use and should be considered in future research. In
addition, relationship and communication quality and the effects these factors have on overall
microbicide acceptability and use as well as the possibility of surreptitious use should be
examined. Specifically these factors should be examined to determine acceptance of covert
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microbicide use as well as what the potential consequences of not telling the partner may be
for the young woman. Vaginal microbicides are a promising prevention strategy and promotion
strategies should address the variable microbicide preferences specific to the target population.
In conclusion, as microbicide development continues attention will need to focus on the impact
of preferred characteristics for adolescent women and how preferences may change as a
function of developmental stage and sexual and contraceptive experience. Young women are
clearly an important target for microbicide promotion and the results of this study suggest that
they have interest in microbicide use. Their preferences will likely influence the focus of
targeted social marketing and education programs for microbicide use. Focusing on young
women will be essential to encourage utilization in this population, which remains at higher
risk for the potential negative effects of sexual initiation and to promote overall healthy sexual
development.
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Figure 1.
Part Worth Utilities for the preference for each characteristic, among the entire sample of
adolescents.
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Table 2
Characteristics of hypothetical microbicides.
Formula Contraception Side effects Timing Target
1 yes yes 15 min before STI
2 yes no 10 min after HIV
3 yes yes 1 hour before HIV
4 no no 15 min before HIV
5 no no 1 hour before STI
6 no yes 10 min after STI
7 no yes 1 hour before HIV
8 yes no 1 hour before STI
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